LAB Cash Flow Breakdown | Standard BioTools Inc.

Standard BioTools Inc. Cash Flow Breakdown

Cash flow breakdown shows where Standard BioTools Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $74.34M went out.
Fiscal year ended 2025-12-31: from investing, $27.41M came in.
Fiscal year ended 2025-12-31: from financing, $570.00K came in.
Fiscal year ended 2025-12-31: change in cash, $45.52M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Buybacks	Debt paid back	New debt	Commercial paper	Staff share tax	New shares sold	Not split out	Change in cash
2025-12-31	-$74.34M	$27.41M	$0.00				-$484.00K*	$531.00K		-$45.52M
2024-12-31	-$143.45M	$363.17M	-$40.49M				-$459.00K	$1.15M	-$62.82M*	$116.32M
2023-12-31	-$43.29M	$20.24M	-$5.41M				-$139.00K	$104.00K	-$1.36M*	-$29.82M
2022-12-31	-$89.37M	-$88.13M	-$563.00K	$0.00			-$211.00K	$97.00K	$231.44M*	$52.86M
2021-12-31	-$44.06M	-$11.95M	$0.00	-$501.00K	$0.00		-$1.79M	$0.00	$18.25M*	-$40.07M
2020-12-31	-$15.42M	$39.98M		$0.00	$0.00		-$459.00K	$20.23M	$1.09M*	$45.80M
2019-12-31	-$35.21M	-$39.30M		-$51.83M	$55.00M		-$629.00K	$0.00		-$71.67M
2018-12-31	-$25.20M	$4.72M		$0.00	$0.00		-$358.00K	$59.47M	-$1.45M*	$37.34M
2017-12-31	-$24.10M	$17.66M		$0.00	$0.00		-$118.00K	$28.79M		$23.01M
2016-12-31	-$39.14M	$45.10M					-$111.00K	$0.00		$5.93M
2015-12-31	-$34.73M	$25.74M		$0.00		$0.00	-$151.00K	$0.00	$5.49M*	-$4.60M
2014-12-31	-$22.62M	-$178.38M		$0.00		$0.00		$5.11M	$195.21M*	-$1.55M
2013-12-31	-$1.59M	-$27.57M		$0.00		$0.00		$5.81M		-$23.39M
2012-12-31	-$17.48M	$14.00M		-$10.19M		$1.88M		$2.70M	$54.13M*	$45.10M
2011-12-31	-$17.54M	-$45.11M		-$4.74M		$0.00		$1.29M	$73.82M*	$7.83M
2010-12-31	-$11.51M	-$1.33M		$0.00		$3.13M		$39.00K	$633.00K*	-$8.88M
2009-12-31	-$19.51M	-$688.00K		-$1.03M				$53.00K	$17.92M*	-$3.19M

Each quarter (3 month)

Quarter end	Running the business	From investing	Buybacks	Debt paid back	Commercial paper	Staff share tax	New shares sold	Not split out	Change in cash
2026-06-30	-$10.31M*	$14.41M*				-$258.00K*	$0.00*
2026-03-31	-$46.60M	$191.09M				-$118.00K	$78.00K		$144.57M
2025-12-31	-$1.19M*	-$8.04M*	$0.00*			-$126.00K*	$531.00K*
2025-09-30	-$22.20M*	-$6.68M*	$0.00*			-$112.00K*	$0.00*
2025-06-30	-$20.67M*	$27.50M*	$0.00*			-$200.00K*	$0.00*
2025-03-31	-$30.28M	$14.63M	$0.00			-$46.00K	$0.00		-$15.35M
2024-12-31	-$14.06M*	$25.73M*	$0.00*			-$45.00K*	$32.00K*	-$54.51M*
2024-09-30	-$27.87M*	-$30.88M*	$0.00*			-$70.00K*	$68.00K*
2024-06-30	-$39.05M*	$50.26M*	-$29.44M*			-$327.00K*	$980.00K*
2024-03-31	-$62.48M	$318.07M	-$11.05M			-$17.00K	$72.00K	-$8.74M*	$235.84M
2023-12-31	-$14.06M*	-$13.12M*	-$174.00K*			$0.00*	$24.00K*	-$853.00K*
2023-09-30	-$11.41M*	-$49.93M*	-$400.00K			-$12.00K*		-$752.00K*
2023-06-30	-$9.33M*	$40.13M*	-$2.40M			-$35.00K*
2023-03-31	-$8.48M	$43.15M	-$2.47M			-$92.00K			$32.13M
2022-12-31	-$19.18M*	$40.24M*	-$563.00K*	$0.00*		-$30.00K*	$0.00*
2022-09-30	-$24.61M*	$10.74M*	$0.00*	$0.00*	$0.00*	-$102.00K*	-$1.00K*
2022-06-30	-$29.99M*	-$138.24M*	$0.00*	$0.00*	$0.00*	$8.00K*		$212.95M*
2022-03-31	-$15.59M	-$868.00K	$0.00			-$87.00K		$18.16M*	$1.53M
2021-12-31	-$7.00M*	-$1.15M*		$0.00*		-$98.00K*	$0.00*	$7.39M*
2021-09-30	-$9.49M*	-$1.71M*		$0.00*	$0.00*	-$143.00K*	-$1.00K*	$9.96M*
2021-06-30	-$14.66M*	-$4.17M*		$0.00*	$0.00*	-$1.03M*
2021-03-31	-$12.90M	-$4.92M		-$501.00K	$0.00	-$525.00K			-$18.78M
2020-12-31	-$3.73M*	-$822.00K*		$0.00*		-$72.00K*	$0.00*
2020-09-30	-$4.60M*	$13.21M*		$0.00*		-$125.00K*	$450.00K*	$20.09M*
2020-06-30	-$2.79M*	$10.13M*		$0.00*		-$116.00K*	$0.00*	$627.00K*
2020-03-31	-$4.29M	$17.46M		$0.00		-$146.00K	$0.00		$12.33M
2019-12-31	-$5.52M*	-$551.00K*				-$73.00K*	$0.00*	$1.86M*
2019-09-30	-$4.55M*	$6.55M*				-$69.00K*	$1.00K*
2019-06-30	-$5.01M*	-$35.54M*				-$379.00K*	$793.00K*
2019-03-31	-$20.13M	-$9.76M				-$108.00K	$255.00K		-$29.77M
2018-12-31	-$638.00K*	-$19.00K*				-$191.00K*	$58.91M*	$1.24M*	$59.57M*
2018-09-30	-$4.06M*	$802.00K*				-$12.00K*	$0.00*		-$3.60M*
2018-06-30	-$4.32M*	$4.20M*				-$108.00K*	$8.00K*	-$1.99M*	-$2.55M*
2018-03-31	-$16.18M	-$263.00K				-$47.00K	$71.00K		-$16.08M
2017-12-31	$661.00K*	-$3.88M*				-$28.00K*	-$50.00K*		-$2.89M*
2017-09-30	-$7.98M*	$448.00K*				$0.00*	$28.84M*		$21.35M*
2017-06-30	-$8.29M*	$3.59M*					$41.00K*		-$4.50M*
2017-03-31	-$8.49M	$17.50M					$3.00K		$9.05M
2016-12-31	-$10.73M*	$13.79M*				-$21.00K*	$0.00*		$2.74M*
2016-09-30	-$13.26M*	$9.82M*					$83.00K*		-$3.59M*
2016-06-30	-$7.35M*	$292.00K*					$129.00K*		-$6.96M*
2016-03-31	-$7.79M	$21.20M					$5.00K		$13.74M
2015-12-31	-$4.40M*	$4.84M*					$219.00K*		$300.00K*
2015-09-30	-$12.70M*	$17.68M*					$144.00K*		$5.07M*
2015-06-30	-$7.83M*	-$6.86M*					$1.40M*		-$13.24M*
2015-03-31	-$9.80M	$10.07M					$3.73M		$3.27M
2014-12-31	-$3.52M*	$5.65M*					$1.03M*		$2.77M*
2014-09-30	-$8.86M*	-$3.95M*					$627.00K*		-$12.74M*
2014-06-30	$312.00K*	-$58.85M*					$1.17M*		-$57.34M*
2014-03-31	-$10.55M	-$121.23M					$2.29M	$195.21M*	$65.76M
2013-12-31	$3.24M*	$9.62M*		$0.00*	$0.00*		$2.31M*		$15.16M*
2013-09-30	-$1.31M*	-$12.06M*		$0.00*	$0.00*		$1.08M*		-$12.19M*
2013-06-30	-$2.64M*	-$27.52M*		$0.00*			$653.00K*		-$29.52M*
2013-03-31	-$884.00K	$2.40M		$0.00			$1.77M		$3.17M
2012-12-31	-$3.50M*	-$2.44M*		$0.00*	$0.00*		$578.00K*	-$2.01M*	-$7.36M*
2012-09-30	-$3.34M*	$5.29M*		-$2.84M*	$0.00*		$819.00K*	$56.14M*	$56.16M*
2012-06-30	-$4.00M*	$6.59M*		-$3.54M*			$526.00K*	$1.88M*	$1.36M*
2012-03-31	-$6.64M	$4.57M		-$3.82M			$780.00K		-$5.06M
2011-12-31	-$2.25M*	$4.96M*		-$1.48M*	$0.00*		$412.00K*		$1.67M*
2011-09-30	-$2.38M*	$4.89M*		-$1.43M*	$0.00*		$634.00K*		$1.75M*
2011-06-30	-$11.68M*	-$32.87M*		-$1.38M*			$89.00K*		-$45.70M*
2011-03-31	-$1.23M	-$22.09M		-$447.00K			$153.00K	$73.73M*	$50.11M
2010-12-31	-$2.26M*	-$334.00K*		$0.00*			$8.00K*	$3.13M*	$640.00K*
2010-09-30	-$3.22M*	-$472.00K*		$0.00*			$20.00K*	$633.00K*	-$2.99M*

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
Perspective Therapeutics, Inc. (CATX)	United States	$0.284B	-3.34
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Sagimet Biosciences Inc. (SGMT)	United States	$0.279B
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01